Home - Products - Others - Other Targets - ent-16beta,17-dihydroxy-9(11)-kauren-19-oic acid

ent-16beta,17-dihydroxy-9(11)-kauren-19-oic acid

CAS No. 55483-24-4

ent-16beta,17-dihydroxy-9(11)-kauren-19-oic acid( —— )

Catalog No. M31919 CAS No. 55483-24-4

ent-16beta,17-dihydroxy-9(11)-kauren-19-oic acid is a natural product of Xanthium, Asteraceae. ent-16beta,17-dihydroxy-9(11)-kauren-19-oic acid can be used as a reference standard.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 630 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock

Biological Information

  • Product Name
    ent-16beta,17-dihydroxy-9(11)-kauren-19-oic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    ent-16beta,17-dihydroxy-9(11)-kauren-19-oic acid is a natural product of Xanthium, Asteraceae. ent-16beta,17-dihydroxy-9(11)-kauren-19-oic acid can be used as a reference standard.
  • Description
    ent-16beta,17-dihydroxy-9(11)-kauren-19-oic acid is a natural product of Xanthium, Asteraceae. ent-16beta,17-dihydroxy-9(11)-kauren-19-oic acid can be used as a reference standard.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    55483-24-4
  • Formula Weight
    334.5
  • Molecular Formula
    C20H30O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Gabapentin enacarbil

    Gabapentin enacarbil is a prodrug for the anticonvulsant and analgesic drug gabapentin.

  • 9-Ethylcarbazole

    9-Ethylcarbazole is an agent of biochemical.

  • Notoginsenoside FP2

    Notoginsenoside FP2 is a natural product isolated from the fruit pedicels of Panax notoginseng and can be used in studies about the treatment of cardiovascular diseases.